Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center study

The American Journal of Medicine

Volumn 81, Issue 5 SUPPL. 1, 1986, Pages 81-90

  Tashkin, Donald P ^a   Ashutosh, Kumar ^a   Bleecker, Eugene R ^a   Britt, E James ^a   Cugell, David W ^a   Cummiskey, Joseph M ^a   Delorenzo, Lawrence ^a   Gilman, Murray J ^a   Gross, Gary N ^a   Gross, Nicholas J ^a   Kotch, Arthur ^a   Lakshminarayan, Sambasiva ^a   Maguire, George ^a   Miller, Matthew ^a   Plummer, Alan ^a   Renzetti, Attilio ^a   Sackner, Marvin A ^a   Skoroqin, Morton S ^a   Wanner, Adam ^a   Watanabe, Suetaro ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE DERIVATIVE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; ORCIPRENALINE;

ADULT; AGED; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SMOKING; TIME; VITAL CAPACITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT;

ADULT; AGED; ATROPINE DERIVATIVES; BRONCHODILATOR AGENTS; CLINICAL TRIALS AS TOPIC; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IPRATROPIUM; LUNG DISEASES, OBSTRUCTIVE; MALE; METAPROTERENOL; MIDDLE AGED; PARASYMPATHOLYTICS; SMOKING; TIME FACTORS; VITAL CAPACITY; CLINICAL TRIALS; ORCIPRENALINE;

EID: 0023048731     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(86)90468-7     Document Type: Article

References (53)

1. Anticholinergic, antimuscarinic bronchodilators
2. Therapeutic aerosols 2-drugs available by the inhaled route (editorial)
3. Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator
4. The effect of Sch 1000 MDI on the mucociliary clearance and lung function of healthy volunteers (abstr)
5. Sputum rheology following treatment with Sch 1000 MDI and orciprenaline MDI (abstr)
6. 99mTc-sulfate particles
7. Effect of aerosol ipratropium bromide (Sch 1000) on sputum viscosity and volume in chronic bronchitis (letter)
8. Sputum viscoelasticity following administration of SCH 1000 MDI (abstr)
9. Ipratropiumbromid in der kontrollierten Klinischen Prufung
10. Bronchodilator action of two different doses of ipratropium bromide (Sch 1000) compared with fenoterol and placebo
11. The short-term bronchodilator effects of fenoterol and ipratropium in asthma
12. Anticholinergika als Bronchodilatatoren
13. A comparative study of atropine sulfate and isoproterenol hydrochloride in chronic bronchitis
14. Bronchodilator action of the anticholinergic drug, ipratropium bromide (SCH 1000), as an aerosol in chronic bronchitis and asthma
15. Comparison of ipratropium bromide and salbutamol by aerosolized solution
16. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma
17. Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema
18. Experience with Atrovent in coal miners
19. The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis
20. The effect of atropine inhalation in “irreversible” chronic bronchitis
21. Comparative trial of a new anticholinergic bronchodilator, SCH 1000, and salbutamol in chronic bronchitis
22. Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis (letter)
23. Bronchodilatation and the site of airway resistance in severe chronic bronchitis
24. Comparative bronchodilator responses to atropine and terbutaline in asthma and chronic bronchitis
25. A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma
26. Effect of inhaled atropine or metaproterenol in patients with chronic airway obstruction and therapeutic serum theophylline levels
27. Impaired atropine responsiveness in asthma: role of atopy
28. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis
29. Variation of drug action on airway obstruction in man
30. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the CIBA symposium (editorial)
31. Spirometric standards for healthy nonsmoking adults
32. Aerosol SCH 1000
33. SCH 1000: a new anticholinergic bronchodilator
34. Asthma: comparative bronchodilator effects of ipratropium bromide and isoproterenol
35. Rebound hyperresponsiveness to muscarinic stimulation after chronic therapy with an inhaled muscarinic antagonist
36. The effect of sequential inhalations of metaproterenol aerosol in asthma
37. Subsensitivity to the bronchodilator action of albuterol produced by chronic administration
38. Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation
39. 2 adrenergic agents
40. A comparison of oral terbutaline and fenoterol in asthma
41. Evaluation of oral fenoterol in chronic asthmatic patients
42. Efficacy and side effects of fenoterol compared with isoproterenol administered by metered dose inhaler in asthma
43. Aerosolized terbutaline sulfate—an evaluation of efficacy and side effects in patients with reversible airway disease
44. A comparative evaluation of fenoterol and terbutaline in the treatment of asthma
45. Long-term study comparing fenoterol and isoproterenol inhalation in asthmatic patients
46. Effect of regular salbutamol inhalations in normal, atopic and asthmatic subjects
47. Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine
48. Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects
49. Lack of bronchial betaadrenoceptor resistance in asthmatics during long-term treatment with terbutaline
50. Cardiopulmonary effects of long-term bronchodilator administration
51. Selective subsensitization of beta-adrenergic receptors in central airways of asthmatics and normal subjects during long-term therapy with inhaled salbutamol
52. Beta adrenergic receptors of polymorphonuclear particulates in bronchial asthma
53. Role of the parasympathetic system in airway obstruction due to emphysema